Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103629
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103629
Table 2 The relationship between treatment style and insurance type and out-of-pocket ratio
Variablesn (%)1Model A
2Model B
3Model C
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
Radiotherapy
Insurance type
URBMI657 (35.11)111
UEBMI332 (49.4)1.874 (1.561-2.25)< 0.0011.823 (1.509-2.203)< 0.0011.949 (1.606-2.365)< 0.001
Out-of-pocket ratio
≤ 60%823 (56.76)111
> 60%166 (15.19)0.124 (0.101-0.152)< 0.0010.124 (0.101-0.152)< 0.0010.118 (0.096-0.146)< 0.001
Chemotherapy
Insurance type
URBMI131 (7.00)111
UEBMI80 (11.90)1.375 (1.139-1.659)0.0011.283 (1.052-1.566)0.0141.333 (1.089-1.632)0.005
Out-of-pocket ratio
≤ 60%136 (9.38)111
> 60%75 (6.86)0.351 (0.294-0.418)< 0.0010.363 (0.302-0.437)< 0.0010.351 (0.291-0.423)< 0.001
Surgery
Insurance type
URBMI742 (39.66)111
UEBMI313 (46.58)0.977 (0.813-1.173)0.8001.075 (0.881-1.312)0.4781.106 (0.904-1.354)0.329
Out-of-pocket ratio
≤ 60%738 (50.9)111
> 60%317 (29)1.599 (1.36-1.88)< 0.0011.351 (1.134-1.609)0.0011.344 (1.126-1.603)0.001
Immunotherapy
Insurance type
URBMI871 (46.55)111
UEBMI307 (45.68)1.889 (1.396-2.556)< 0.0011.763 (1.292-2.406)< 0.0011.755 (1.281-2.403)< 0.001
Out-of-pocket ratio
≤ 60%598 (41.24)111
> 60%580 (53.06)0.683 (0.507-0.92)0.0120.729 (0.538-0.989)0.0420.699 (0.514-0.951)0.023
Targeted
Insurance type
URBMI131 (7)111
UEBMI80 (11.9)3.702 (2.393-5.727)< 0.0013.525 (2.253-5.515)< 0.0013.857 (2.443-6.089)< 0.001
Out-of-pocket ratio
≤ 60%136 (9.38)111
> 60%75 (6.86)0.224 (0.127-0.394)< 0.0010.229 (0.129-0.407)< 0.0010.215 (0.12-0.385)< 0.001